GlassScriptPhysician profile
Ajay P Reddy
NPI 1679593685
$11,641.69
in general payments reported to CMS, 2019-2025
45 companies · $1,390 in 2025
The $1,390 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,309 · 2020: $1,295 · 2021: $2,762 · 2022: $1,585 · 2023: $1,297 · 2024: $2,003 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,690.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,820.91 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $1,431.18 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $1,260.15 | 2021 | |
| Lilly USA, LLC | $869.03 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $681.09 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $656.14 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Allergan, INC. | $552.01 | 2019-2020 | |
| Pfizer INC. | $508.75 | 2019-2025 | |
| Amgen INC. | $460.23 | 2019-2025 | Repatha, Repatha, Evenity |
| Janssen Pharmaceuticals, INC | $365.33 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $354.64 | 2022-2025 | |
| Amneal Pharmaceuticals LLC | $227.69 | 2021-2024 | Unithroid |
| Merck Sharp & Dohme LLC | $223.30 | 2019-2022 | |
| Astellas Pharma US INC | $221.95 | 2019-2024 | Veozah |
| Sunovion Pharmaceuticals INC. | $185.26 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.